Status:
COMPLETED
Dexcom Continuous Glucose Monitoring in Long-term Care
Lead Sponsor:
Emory University
Collaborating Sponsors:
DexCom, Inc.
Conditions:
Diabetes
Diabetes Mellitus, Type 2
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The goal of this study is to determine whether the use of Dexcom Continuous Glucose Monitoring with Glucose Telemetry System (CGM-GTS) with hypoglycemia alarm will facilitate diabetes treatment and re...
Detailed Description
The prevalence of diabetes increases with age, and it is estimated that more than 20% of older adults aged 65-75 years and 40% of adults over 80 years of age have diabetes. The prevalence of diabetes ...
Eligibility Criteria
Inclusion
- Males and females admitted to subacute and long-term skilled nursing care facilities.
- Known history of T2D treated with insulin or insulin secretagogues with or without additional oral antidiabetic agents, short- and long-acting glucagon-like peptide-1 receptor agonists (GLP-1 RA).
- Patients with an expected long-term care facility length-of-stay \> 1 week.
Exclusion
- Patients expected to require MRI procedures during admission.
- Patients with clinically relevant hepatic disease (diagnosed liver cirrhosis and portal hypertension), corticosteroid therapy, end-stage renal disease (dialysis), or anasarca (massive peripheral edema).
- Female subjects who are pregnant or breast-feeding at time of enrollment into the study.
Key Trial Info
Start Date :
April 19 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 21 2022
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04818242
Start Date
April 19 2021
End Date
October 21 2022
Last Update
November 13 2023
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
A.G. Rhodes
Atlanta, Georgia, United States, 30329
2
Emory Wesley Woods Hospital
Atlanta, Georgia, United States, 30329